The customer would like the run data file investigated to determine a possible cause for the elevated white blood cell (wbc) content in the platelet product.There was not a transfusion recipient or patient involved at the time of the residual white blood cell (rwbc) testing, therefore no patient information is reasonably known at the time of the event.Donor unit #: (b)(4).The platelet collection set is not available for return because it was discarded by the customer.This product is not available within the us, but this report is being filed due to an alleged failure that could occur on a similarly marketed device platform cleared for use by the fda.
|
This report is being filed to provide in corrected information is provided in investigation: the device history records (dhr) were reviewed for this lot.There were noevents noted in the dhr that would have contributed to the elevated wbc count experiencedby the customer.The run data file (rdf) was analyzed for this event.Root cause: a definitive root cause for the observed leukoreduction failure remainsundetermined at this time.The run data file analysis did not show a conclusive root cause for the higher- than-expected wbccontent in the platelet product reported for this collection.Analysis of the rbc detector signalshowed that platelets took longer than expected to initially exit the lrs chamber.This meansthat there was a delay between when the trima accel device predicted that platelets werecollecting and when they actually started collecting platelets in the bag.However, it is possible,though not conclusive, that some wbcs may have been escaping the lrs chamber along with theplatelets during the collection.Based on the available information, it is possible that thisleukoreduction failure may be donor related.
|